Loading clinical trials...
Loading clinical trials...
A Multi-center, Randomized, Double-blind, and Placebo-controlled Phase II Clinical Study to Investigate the Safety and Efficacy of Two Doses of KT07 Compared to Placebo in Subjects With Acute Uncomplicated Influenza
Conditions
Interventions
KT07 Capsule
Placebo
Locations
81
United States
Central Alabama Research
Birmingham, Alabama, United States
Parkway Medical Center, LLC
Birmingham, Alabama, United States
Cahaba Research, Inc.
Birmingham, Alabama, United States
David Wever
Pelham, Alabama, United States
Alliane Urgent Care
Tolleson, Arizona, United States
Orange County Research Institute
Anaheim, California, United States
Start Date
September 1, 2016
Primary Completion Date
July 31, 2020
Completion Date
July 31, 2020
Last Updated
August 31, 2020
NCT06355232
NCT04494412
NCT07204964
NCT05110911
NCT06622590
NCT05227001
Lead Sponsor
Yiling Pharmaceutical Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions